Kohl’s Corporation stocks have been trading down by -8.09 percent amid mounting concerns over weakening consumer demand and sales.

Weekly Update May 25 – May 29, 2026: On Sunday, May 31, 2026 Kohl’s Corporation stock [NYSE: KSS] is trending down by -8.09%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Consumer Discretionary industry expert:

Analyst sentiment – negative

Kohl’s occupies a challenged but solvent mid-tier department store position, with EBIT margin at 4% and net margin below 2%, underscoring weak pricing power in a declining top-line (3-year revenue CAGR about -5%). However, gross margin at 40.6% and asset turnover of 1.2 show the core box can still generate cash. Free cash flow of $686M versus a ~$5.1B EV and P/FCF of 0.6 screen as deeply value. Leverage is manageable (total debt/equity 1.0x, interest coverage 4.6x), but ROE near 8% is subpar.

Technically, shares have staged a sharp rebound from the low teens, with weekly closes lifting from ~$13.17 to ~$14.33, but the pattern is choppy and lacks confirmation of a durable uptrend. Prior spikes to $15.60 failed quickly, defining a key resistance zone at $15.50–$15.75. With recent intraday action showing fading volume on rallies, I would treat $13.00–$13.25 as pivotal support: tactical longs only above $13.25 with tight stops below $12.90.

More Breaking News

• CareDx CDNA Soars After Earnings Beat And Guidance Hike
• Global Payments Stock Climbs As Analysts Hike Price Targets
• GoDaddy Stock Jumps As Q3 Beat And AI Airo Fuel Bullish Outlook
• FDXF Stock Climbs As Price Action Attracts Momentum Traders

Near term, guidance for FY26 EPS of $1.00–$1.60 below or just in line with consensus and continuing negative-to-flat comps confirm Kohl’s as a secular share-loser versus Consumer Discretionary and Retail – Discretionary peers growing low to mid-single digits. Street sentiment is weak, with multiple Underperform/Sell ratings and targets clustered around $14–$19. My base case: fair value ~$14 and a trading range of $12 support to $16 resistance, skewed to downside risk if comps deteriorate.

Quick Financial Overview

Kohl’s Corporation (KSS) is trying to stabilize, not break out. Management’s FY26 adjusted EPS range of $1.00–$1.60 sits around the Street’s $1.36 midpoint, while sales are guided flat to slightly down versus about $14.87B. For traders, that is a message of “no collapse, but no clear growth engine,” which caps the upside narrative. The latest fiscal Q1 showed a loss of $0.13 per share, slightly better than the expected $0.16 loss, so execution is improving against low expectations but the business is still in the red.

Under the hood, the financials look like a low-multiple, low-growth retailer. Revenue sits near $15.53B with a solid 40.6% gross margin, yet profit margins are thin, around 1.75% at the bottom line and roughly 4% at EBIT. A price-to-sales ratio of 0.1 and price-to-book near 0.4 suggest the market is already discounting a lot of bad news. Leverage is meaningful, with total debt-to-equity around 1.03 and interest coverage at 4.6 times, but not yet at stress levels. Cash generation is a positive: recent free cash flow of about $686M and operating cash flow of $750M show the model still throws off cash.

The chart tells you the Street is debating value versus decay. Recently, KSS traded in the mid-teens, with a weekly move from about $15.56 down toward $14.33, and another bar showing rejection from $13.43 back near $13.30. That kind of choppy action fits the mixed analyst backdrop: a consensus Hold and average target near $15.05, while BofA sits at $14 and UBS at $9 with a Sell. Intraday, a 5-minute candle showing a fade from roughly $15.16 to $14.36 after tagging $15.46 intraday says sellers are hitting strength. Add a roughly 3.5% dividend yield on a $0.50 annual payout, and you have a stock where income, value, and downside risk all pull against each other.

Conclusion

Kohl’s Corporation sits in a tight spot where value arguments meet real structural risk. Guidance around flat to slightly negative sales and modest EPS for FY26 tells traders not to expect a sharp growth turn anytime soon. The Q1 loss came in better than feared, which can fuel short bursts of relief buying, but persistent unprofitability keeps many funds cautious. On top of that, sell-side moves are leaning bearish: BofA cutting the target to $14 with an Underperform and UBS sticking to a Sell even after a slight target lift to $9 underline downside worries.

On the tape, KSS has been rejected on pushes into the mid-teens and has slipped back toward the low-to-mid teens, matching the cluster of price targets around $14–$15. That zone will matter; sustained trade above it would signal the market is starting to believe in stabilization, while repeated failures there keep the short side in control. For short-term traders, this is a name where you fade strength into known target bands rather than chase breakouts, unless the fundamentals clearly shift. As I tell my students, “The market pays you for trading what is, not what you hope a turnaround story will become.” That’s why I also remind traders of a complementary rule: As Tim Bohen, lead trainer with StocksToTrade says, “I focus on what a stock is doing, not what I want it to do. Let the stock prove itself before you make a move.”.

This is stock news, not investment advice. StocksToTrade News delivers real-time stock market updates tailored to highlight the key catalysts driving short-term price movements. Our coverage is designed for active traders and investors who thrive in fast-moving markets, with a focus on volatile sectors like penny stocks, AI stocks, Robinhood stocks and other momentum plays. From earnings reports and FDA approvals to mergers, new contracts, and unusual trading volume, we break down the events that can spark significant price action.

Looking to level up your trading game? Explore StocksToTrade, the ultimate platform for traders. With powerful tools designed for swing and day trading, integrated news scanning, and even social media monitoring, StocksToTrade keeps you one step ahead.

Check out our quick startup guide for new traders!

• How to Read Stock Charts: A Guide for Beginners
• Trading Plan: 6 Steps to Create One
• How To Create a Stock Watchlist

Ready to build your watchlists? Check out these curated lists:

• AI Penny Stocks
• Robinhood Penny Stocks
• Top Biotech Stocks

Once your watchlist is set, take the next step and trade with confidence using StocksToTrade’s robust platform. Don’t miss out — grab your 14-day trial for just $7 and experience the edge you need to thrive in today’s fast-paced markets.